The sale will involve the transfer of manufacturing facilities in Covina, California; Tijuana, Mexico; Ascoli, Italy and a portion of Pall’s operations in Fajardo, Puerto Rico. Approximately 1300 Pall employees will move to Haemonetics.
The deal is expected to close at the beginning of Pall’s fiscal year 2013, which starts on 1 August 2013.
Pall will also transfer related blood media manufacturing capability to Haemonetics by 2016. Until this transfer is completed, Pall will provide these media products to Haemonetics under a supply agreement.
